Aesop Cho
56Patents
25h-index
104Co-inventors
91Inventor score
Filing activity: Sep 21, 2000 → Dec 1, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8008264B2 | 1′-substituted carba-nucleoside analogs for antiviral treatment | Emerging Cross-Sectional Technologies | 108 | Active |
| US7973013B2 | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment | Chemistry; Metallurgy | 107 | Active |
| US8012941B2 | Carba-nucleoside analogs for antiviral treatment | Emerging Cross-Sectional Technologies | 99 | Active |
| US8318682B2 | 1′substituted carba-nucleoside analogs for antiviral treatment | Emerging Cross-Sectional Technologies | 95 | Active |
| US8012942B2 | Carba-nucleoside analogs for antiviral treatment | Emerging Cross-Sectional Technologies | 93 | Active |
| US8415308B2 | 1′-substituted-carba-nucleoside prodrugs for antiviral treatment | Chemistry; Metallurgy | 92 | Active |
| US8455451B2 | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment | Human Necessities | 88 | Active |
| US9090642B2 | Methods for the preparation of diasteromerically pure phosphoramidate prodrugs | Chemistry; Metallurgy | 87 | Active |
| US7452901B2 | Anti-cancer phosphonate analogs | Chemistry; Metallurgy | 69 | Expired |
| US8853171B2 | 1′-substituted carba-nucleoside analogs for antiviral treatment | Emerging Cross-Sectional Technologies | 62 | Active |
| US8088368B2 | Antiviral compounds | Chemistry; Metallurgy | 57 | Active |
| US7645747B2 | Therapeutic phosphonate compounds | Chemistry; Metallurgy | 57 | Expired |
| US8877733B2 | 1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment | Chemistry; Metallurgy | 46 | Active |
| US8022083B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 44 | Active |
| US9487544B2 | Methods for the preparation of diasteromerically pure phosphoramidate prodrugs | Chemistry; Metallurgy | 43 | Active |
| US7300924B2 | Anti-infective phosphonate analogs | Chemistry; Metallurgy | 37 | Expired |
| US10023600B2 | Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs | Human Necessities | 35 | Active |
| US6596723B1 | Fungal efflux pump inhibitors | Chemistry; Metallurgy | 34 | Expired |
| US8273341B2 | Antiviral compounds | Chemistry; Metallurgy | 33 | Active |
| US8871785B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 33 | Active |
| US7417055B2 | Kinase inhibitory phosphonate analogs | Chemistry; Metallurgy | 28 | Expired |
| USRE46762E1 | 1′-substituted carba-nucleoside analogs for antiviral treatment | General | 27 | Active |
| US10988498B2 | Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs | Human Necessities | 27 | Active |
| US7407965B2 | Phosphonate analogs for treating metabolic diseases | Human Necessities | 26 | Expired |
| US9139604B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 26 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.